Navigation Links
LabRoots to Host DiaSorin Webinar That Fills in Common Knowledge Gaps About Epstein-Barr Virus Infection
Date:4/25/2016

Despite the fact that infectious mononucleosis has been known as a unique disease for more than 100 years, and that Epstein-Barr virus—which causes it—was discovered more than 50 years ago, no licensed vaccine or clear-cut effective treatment for infections due to this virus yet exists. Have you ever wondered why this is?

DiaSorin is sponsoring a new, free educational webinar, “Epstein-Barr Virus Infections: Pay Me Now or Pay Me Later,” which will provide ample answers. The webinar will discuss the clinical findings and laboratory tests for diagnosing and staging primary Epstein-Barr virus (EBV) infection; mechanisms EBV uses to cause cancer and autoimmune diseases, especially multiple sclerosis; and research approaches toward preventing EBV infection. We all acquire EBV at some time during our lives, and the question we will be answering is whether it is better to get it sooner or later. Continuing education credits will be offered through the PACE system.

Attendees will learn how to evaluate clinical findings and lab tests used to diagnose EBV infection, discuss probable mechanisms of EBV-spurred cancers and autoimmune disease, and evaluate approaches to prevention of EBV infections.

The speaker is Henry Balfour, Jr, MD, professor of pediatrics in the Division of Infectious Diseases, and professor of laboratory medicine and pathology, where he serves as medical director of the University of Minnesota Clinical Virology Laboratory. Dr. Balfour is an internationally recognized expert in the diagnosis and treatment of viral infections, especially those due to herpes virus infections and HIV. He received an MD degree from Columbia University, completed an internship and residency at the University of Minnesota and Columbia-Presbyterian Medical Center, served as a pediatrician in the Air Force, and completed a post-doctoral fellowship in Infectious Disease at the University of Minnesota.

The free webinar, hosted by LabRoots, will be presented on May 17, 2016, at 10 am PT/12 pm CT/1 pm ET.

For full details about the event, obtaining continuing education credits, and free registration, click here.

About DiaSorin:
DiaSorin Inc. offers the broadest, fully automated Infectious Disease and Specialty Diagnostics menu including the Best-in-Class Vitamin D. These quality assays are analyzed on the versatile LIAISON® XL platform. We provide value through sales, service and support solutions to clinical laboratories by consolidating their menu in order to streamline processes and increase efficiency.

About LabRoots:
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at http://www.prweb.com/releases/2016/04/prweb13365303.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. LabRoots Announces New Educational Webinar on Next-Generation Sequencing
2. Latest Advances in Clinical Diagnostics and Research: A LabRoots 2015 Virtual Event
3. LabRoots to Host Inova Diagnostics Clinical Webinar Presenting Health Economic Value of Calprotectin Testing: A Gastroenterologist's Perspective
4. LabRoots Announces Beckman Coulter's Webinar Discussing Flow Cytometric Analysis of Human T Cells
5. LabRoots to Host Wyatt Technology Webinar that Unpacks the Light Scattering Toolkit
6. LabRoots Hosts Thermo Scientific Webinar that Turns Up the Heat on Designer Drugs for Forensic Toxicology Labs
7. LabRoots Hosts SCIEX Webinar That Helps Scientists Benefit from Unique Capabilities of CESI-MS
8. LabRoots Hosts Beckman Coulter Life Sciences Webinar that Showcases an Innovative Approach to Traditional Technology
9. LabRoots Hosts Beckman Coulter Webinar that Posits Phenotyping Method for Human Innate Lymphoid Cells with Flow Cytometry
10. LabRoots Hosts Cell Signaling Technology Webinar that Showcases Tools for the study of Tumor Immunology
11. LabRoots Hosts Beckman Coulter Webinar that Explores Extracellular Vesicle Detection and Analysis Via Flow Cytometry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... ... specializing in medical device compliance and commercialization, has just released a new ... , FDA is more adamant than ever about medical device, pharmaceutical, and ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part of The Garland ... a redesigned website. The new site – still located at http://www.garlandco.com ... and other industry users that Garland serves. , After an ambitious phase of ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... digital and social campaign, “Humans With Vaginas.” The goal is to ignite conversation ... of non-toxic personal care products. The brand has declared September “Humans with Vaginas” ...
(Date:9/20/2017)... ... 20, 2017 , ... Health & Safety Institute (HSI) is offering discounted pricing ... 40-Hour courses from now until November 30, 2017 to assist with the clean-up efforts ... to all businesses and government agencies – whether or not they will be directly ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the exciting story of ... life. This mouse sets out on a journey that will show that friends are ... creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
Breaking Medicine Technology: